Trevi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.About TRVI
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease, and refractory chronic cough.
TRVI Key Statistics
Stock Snapshot
As of today, Trevi Therapeutics(TRVI) shares are valued at $13.94. The company's market cap stands at 1.98B, with a P/E ratio of -42.89.
On 2026-05-01, Trevi Therapeutics(TRVI) stock moved within a range of $13.71 to $14.08. With shares now at $13.94, the stock is trading +1.6% above its intraday low and -1.0% below the session's peak.
Trading volume for Trevi Therapeutics(TRVI) stock has reached 186.2K, versus its average volume of 2.44M.
Over the past 52 weeks, Trevi Therapeutics(TRVI) stock has traded between a high of $16.12 and a low of $5.38.
Over the past 52 weeks, Trevi Therapeutics(TRVI) stock has traded between a high of $16.12 and a low of $5.38.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.